| Literature DB >> 3741522 |
R C Allen, K R Gross, R M Laxer, P N Malleson, R D Beauchamp, R E Petty.
Abstract
The use of intraarticular triamcinolone hexacetonide in the management of persistent arthritis of the knee joint that is unresponsive to nonsteroidal anti-inflammatory drugs was prospectively evaluated in 40 children with chronic arthritis. Of 49 knees that were injected, 63.3% maintained complete resolution of effusion and other signs of inflammation at the 6-month followup. This favorable outcome correlated with a young age, a short disease duration, and a higher dose of triamcinolone hexacetonide. At the 12-month followup, 45% of the injected knees remained in remission.Entities:
Mesh：
Substances：
Year: 1986 PMID： 3741522 DOI： 10.1002/art.1780290808
Source DB: PubMed Journal: Arthritis Rheum ISSN： 0004-3591